9999999997-16-027998.txt : 20161222 9999999997-16-027998.hdr.sgml : 20161222 20161222153859 ACCESSION NUMBER: 9999999997-16-027998 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20161222 DATE AS OF CHANGE: 20161222 20161222 20161222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 162066504 BUSINESS ADDRESS: STREET 1: 130 BROOKLINE STREET STREET 2: SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 130 BROOKLINE STREET STREET 2: SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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